Impact of naproxen sodium (Nalgesin® forte) treatment on the performance of daily activities in patients with low back pain or osteoarthritis in regular clinical practice (QLIFE)

26/11/2025
26/11/2025
EU PAS number:
EUPAS1000000831
Study
Finalised

ENCePP Code of conduct

No
Data sources

Data sources (types)

Non-interventional study
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Yes

Check completeness

Yes

Check stability

No

Check logical consistency

Yes
Data characterisation

Data characterisation conducted

Yes